01:43 AM EDT, 09/30/2026 (MT Newswires) -- Dallah Healthcare (SASE:4004) appointed Muteab bin Abdullah Altukeas as chief executive officer, effective Wednesday, according to a same-day release. The Saudi Arabian healthcare company named Altukeas, who previously served as chief strategy officer since 2022, as acting CEO in August 2026.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.